Lawrence Horowitz - Atherton CA, US Ramesh Bhatt - Belmont CA, US Arun K. Kashyap - San Francisco CA, US
Assignee:
Sea Lane Biotechnologies, LLC - Atherton CA
International Classification:
G01N 33/53 C07H 21/04
US Classification:
435 71, 536 2353
Abstract:
The present invention concerns donor-specific antibody libraries derived from a patient donor who has suffered from, or is suffering from one or more diseases discussed herein. The present invention also concerns the method of making and using the donor-specific antibodies. The present invention further concerns the neutralizing antibodies obtained from the donor-specific antibody libraries and the methods of using these antibodies for the prevention/treatment of human disease.
The present invention concerns methods and means for identifying, producing, and engineering neutralizing antibodies against influenza A viruses, and to the neutralizing antibodies produced. In particular, the invention concerns neutralizing antibodies against various influenza A virus subtypes, including neutralizing antibodies against two or more of H1, H2, H3, H5, H7 and H9, such as, for example all of H1, H2, H3, and H5 subtypes, and methods and means for making such antibodies. More specifically, the invention concerns antibodies capable of neutralizing more than one, preferably all, isolates of an influenza A virus subtype.
The present invention concerns methods and means for identifying, producing, and engineering neutralizing molecules against influenza A viruses, and to the neutralizing molecules produced. In particular, the invention concerns neutralizing molecules against various influenza A virus subtypes, including neutralizing antibodies against H5 and/or H3 and/or H1, such as, for example all of H1, H3, and H5 subtypes, and methods and means for making such molecules.
The present application concerns donor-specific antibody libraries derived from a patient donor who has suffered from, or is suffering from one or more diseases discussed herein. The present application also concerns the method of making and using the donor-specific antibodies. The present application further concerns the neutralizing antibodies obtained from the donor-specific antibody libraries and the methods of using these antibodies for the prevention/treatment of human disease.
Lawrence Horowitz - Atherton CA, US Ramesh Bhatt - Belmont CA, US Arun K. Kashyap - Newark CA, US
International Classification:
A61K 39/42 C07K 16/08 A61P 31/16
US Classification:
4241591, 5303871
Abstract:
The present invention concerns methods and means for identifying, producing, and engineering neutralizing antibodies against influenza A viruses, and to the neutralizing antibodies produced. In particular, the invention concerns neutralizing antibodies against various influenza A virus subtypes, including neutralizing antibodies against two or more of H1, H2, H3, H5, H7 and H9, such as, for example all of H1, H2, H3, and H5 subtypes, and methods and means for making such antibodies. More specifically, the invention concerns antibodies capable of neutralizing more than one, preferably all, isolates of an influenza A virus subtype.
Lawrence HOROWITZ - Atherton CA, US Ramesh Bhatt - Belmont CA, US Arun Kashyap - Newark CA, US
International Classification:
A61K 39/145 A61P 31/16 A61P 37/04 A61K 39/395
US Classification:
4241591, 4242101
Abstract:
The present invention concerns methods and means for identifying, producing, and engineering neutralizing molecules against influenza A viruses, and to the neutralizing molecules produced. In particular, the invention concerns neutralizing molecules against various influenza A virus subtypes, including neutralizing antibodies against H5 and/or H3 and/or H1, such as, for example all of H1, H3, and H5 subtypes, and methods and means for making such molecules.
Lawrence HOROWITZ - Atherton CA, US Ramesh Bhatt - Belmont CA, US Arun K. Kashyap - Newark CA, US
International Classification:
A61K 39/42 A61P 31/16
US Classification:
4241591
Abstract:
The present invention concerns methods and means for identifying, producing, and engineering neutralizing antibodies against influenza A viruses, and to the neutralizing antibodies produced. In particular, the invention concerns neutralizing antibodies against various influenza A virus subtypes, including neutralizing antibodies against two or more of H1, H2, H3, H5, H7 and H9, such as, for example all of H1, H2, H3, and H5 subtypes, and methods and means for making such antibodies. More specifically, the invention concerns antibodies capable of neutralizing more than one, preferably all, isolates of an influenza A virus subtype.
The present invention concerns methods and means for identifying, producing, and engineering neutralizing antibodies against influenza A viruses, and to the neutralizing antibodies produced. In particular, the invention concerns neutralizing antibodies against various influenza A virus subtypes, and methods and means for making such antibodies.
Eaton Mar 2017 - Jun 2019
Plant Manager
Eaton Jan 2015 - Mar 2017
Continuous Improvement Manager - B Line Divison
Eaton Aug 2011 - Dec 2014
Quality Manager
Eaton May 2008 - Jul 2011
Opex Manager - Electrical Solutions and Services - Emea \ Integration Manager For Acquistion In Me
Hubbell Incorporated May 2008 - Jul 2011
Plant Manager
Education:
Duke University - the Fuqua School of Business 2002 - 2003
Master of Business Administration, Masters
University of South Florida 1990 - 1993
Master of Science, Masters, Engineering
Anna University 1985 - 1989
Bachelors, Bachelor of Science, Mechanical Engineering
Skills:
Lean Manufacturing Value Stream Mapping Dmaic Continuous Improvement Six Sigma Manufacturing Kaizen Manufacturing Engineering 5S Fmea Quality Management Cross Functional Team Leadership Engineering Failure Mode and Effects Analysis
Arch Oncology
Vice President, Research
Compugen Usa
Director, Antibody Discovery
Biotherapeutics Consulting
Principal Consultant
Protagonist Therapeutics Sep 2012 - Aug 2014
Research Fellow
Sea Lane Biotechnologies Feb 2008 - Sep 2012
Director of Biology
Education:
University of California, Santa Cruz 1995 - 2001
Doctorates, Doctor of Philosophy, Biology, Philosophy
University of California
University of California, Berkeley
Bachelors, Zoology
Skills:
Protein Chemistry Biotechnology Molecular Biology Antibodies Biochemistry Cell Culture Assay Development Drug Discovery Elisa Monoclonal Antibodies Cell Biology Phage Display Publications Patent Applications Cell Immunology
Kashyap Development Associates
Principal
United Nations Oct 2011 - Aug 2015
Un Resident Coordinator and Undp Resident Representative and Designated Officer For Security
Undp Jan 2011 - Apr 2011
Senior Advisor To the Director Asia Pacific Regional Center
Undp Sep 2009 - May 2010
Officer-In-Charge
Undp 2004 - 2010
Senior Advisor, Private Sector Development
Education:
University of Hawaii at Manoa 1982 - 1990
Doctorates, Doctor of Philosophy, Economics, Business
Skills:
International Development International Relations Policy Climate Change Capacity Building Project Planning Policy Analysis Sustainable Development Strategy Climate Change Adaptation Government Human Rights Ngos Public Policy Economics Public/Private Partnerships Fundraising Corporate Social Responsibility Civil Society Economic Development Capacity Development Climate Humanitarian Assistance Africa Public Private Partnerships Non Governmental Organizations